SUBSTITUTED PYRIMIDIN-4(3H)-ONES FOR USE IN TREATING CANCER
The present disclosure provides a method of treating cancer or a solid tumor (e.g., an advanced or metastatic solid tumor) in a subject with a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, conformational isomer, t...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
16.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides a method of treating cancer or a solid tumor (e.g., an advanced or metastatic solid tumor) in a subject with a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, conformational isomer, tautomer, or a combination thereof, where the subject has one or more mutations in the MAPK pathway and/or one or more mutations in |
---|---|
Bibliography: | Application Number: AU20220360835 |